Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Toplak

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Diabetes Care|June 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECTIldiko Lingvay, John Deanfield, Steven E Kahn, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Cardiovascular diseases and heart failure in diabetes: diagnostics and management (Update 2026)]Matthias W Heinzl, Michael Resl, Julian Maier, et al.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2]Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, et al.
Obesity Facts|July 25, 2017
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health RiskJohannes Hebebrand, Jens-Christian Holm, Euan Woodward, et al.
European Journal of Preventive Cardiology|June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
American Journal of Preventive Cardiology|June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Wiener Klinische Wochenschrift|April 8, 2016
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 updateHermann Toplak, Bernhard Ludvik, Monika Lechleitner, et al.
Wiener Medizinische Wochenschrift (1946)|August 28, 2013
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!Max Pichler, Dominik Lautsch, Claudia Adler, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Diabetes Care|June 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECTIldiko Lingvay, John Deanfield, Steven E Kahn, et al.
Atherosclerosis Plus|January 16, 2023
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Cardiovascular diseases and heart failure in diabetes: diagnostics and management (Update 2026)]Matthias W Heinzl, Michael Resl, Julian Maier, et al.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2]Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, et al.
Obesity Facts|July 25, 2017
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health RiskJohannes Hebebrand, Jens-Christian Holm, Euan Woodward, et al.
European Journal of Preventive Cardiology|June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
American Journal of Preventive Cardiology|June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Wiener Klinische Wochenschrift|April 8, 2016
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 updateHermann Toplak, Bernhard Ludvik, Monika Lechleitner, et al.
Wiener Medizinische Wochenschrift (1946)|August 28, 2013
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!Max Pichler, Dominik Lautsch, Claudia Adler, et al.
Pageof 8